On Thursday 3 May Imperial College Health Partners are proudly hosting the ‘ Global Investor Forum ’, providing an opportunity for promising healthcare start-ups from all over Europe to pitch to investors.
Being held at London’s Silicon Valley Bank in partnership with EIT Health and supported by Health XL this event will bring together international investors and highly regarded healthcare innovators for a day of curated match-making, networking opportunities, speakers and pitches.
These healthcare innovators have all previously been finalists in EIT Health Accelerator programmes and have been selected by EIT Health and the NHS Innovation Accelerator as the best and brightest in European high-potential health entrepreneurship.
The event will enable the formation of partnerships to help innovators to scale, grow and make an impact to people’s lives. The day will present a diverse range of exciting opportunities in healthcare, with innovators travelling from across Europe to take part in this unique opportunity.
Dr. Axel Heitmueller, Managing Director at Imperial College Health Partners, said:
“This is an exciting time for healthcare innovation. Forums like these are crucial in bridging perspectives, creating shared understanding and forming lasting partnerships. I am immensely proud that ICHP are continuing to lead alongside forward thinking organisations like EIT Health and HealthXL, bringing together significant investors to enable healthcare innovation to make lasting impact for patients.”
Topics for the day will include:
• Building Scalable Business in Healthcare: A Global Viewpoint
• Connected Healthcare – Personalized Medicine
• Building a Revenue Model that Works – Novel Forms of Investment
• Capital Raising in Europe: Challenges for Both Investors & Innovators
• Biotech, Medtech & Digital Health Company Pitches
Confirmed representation includes:
Marco Mohwinckel, Vice President Strategy, WebMD & Medscape
Sarah Fisher, Senior Director, Global Markets, Johnson & Johnson
Marc Slujis, Advisor, Global Health Innovation Fund, Merck
Bill Gaussa, Head of Advanced Innovation, Philips Healthcare
Vishal Gulati, Healthtech VC, Draper Esprit plc
Steve Seuntjens, Partner, PHS Fund Solutions
Dr Rainer Strohmenger, General Partner, Wellington Partners
Francesca Wuttke, Managing Director, MSD Global Health Innovation Fund, Merck LLC